The product portfolio consists of both new, innovative formulations of established drug substances and generic drugs for use in hospitals.
FrostPharma attributes its success to its ability to match specific needs of patients and healthcare with relevant products and uses expertise in sales and marketing to quickly generate sales.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze